NCT07008820

Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 50 (estimated)
• Sponsor: Bristol-Myers Squibb · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This study will examine quality of life, experiences, and unmet needs among individuals diagnosed with Low Risk Myelodysplastic Syndrome who are erythropoietin stimulating agent naïve and non-transfusion dependent and among individuals with suspected myelodysplastic syndromes with unexplained anemia in Japan

Conditions

• Myelodysplastic Syndrome (MDS)

Interventions

Type	Name	Description
OTHER	Health-related quality of life questionnaires	Questionnaires include: EORTC-QLQ C30 FACT-An PGI-S EQ-5D-5L
OTHER	Qualitative interviews	For participants that meet eligibility criteria

Timeline

• Start date: 2025-05-13
• Primary completion: 2026-02-28
• Completion: 2026-02-28
• First posted: 2025-06-06
• Last updated: 2025-12-04

Locations

1 site across 1 country: Japan